InvestorsHub Logo
Followers 53
Posts 1789
Boards Moderated 0
Alias Born 03/22/2015

Re: Couch post# 238906

Friday, 01/13/2017 8:50:26 AM

Friday, January 13, 2017 8:50:26 AM

Post# of 403543
It could be Purdue AND Pfizer.



You do realize Pfizer pays Purdue royalty fees for Embeda patent infringement rights don't you???

Pfizer isn't going to sue Elite - it doesn't have a leg to stand on. If anyone is going to sue Elite it is going to be Purdue.......but here's the funniest part..........Teva and Epic pharma screwed Purdue - LMAO!!!




Purdue could sue for royalties and Pfizer could sue for exclusivity. Any licensee or assignee of a patent has standing to sue for infringement. These two companies are in court so much they keep extra teams of lawyers in suspended animation in their basement storage lockers. They have an endless supply. Why wouldn't one or both sue? It's what they do and how the how the whole system works.



Nobody is going to pull one over on Elite - Purdue's main ADT patents were ruled to be invalid.

So BS on the whole Elite will be tied up in court for years.





I'm not aware of any successful challenges to the validity naltrexone subunit patent that is listed for both Embeda and Troxyca. Their hard shell ADF patents are invalidated as "obvious." Elite's argument is going to be that the antagonist ADF concept is "obvious" and the mechanism of sequestration is what can be patented. And Elite will win.




Besides Elite hired the previous FDA lead attorney. Good luck on that legal front. LMAO!!!




Pretty obvious Nasrat knows what is coming.



Historic note: Until his life's destiny was further clarified, Robin Hood spent several years robbing from the rich and giving to the porcupines. (G. Larson 7/26/82)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News